Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (symbol: HUM) is a leading private health insurer in the United States, with a primary focus on Medicare Advantage plans. The company has carved out a significant niche in the healthcare market by specializing in government-sponsored programs. Nearly all of Humana's medical memberships come from individual and group Medicare Advantage plans, Medicaid, and the military's Tricare program. This makes it a pivotal player in providing health insurance solutions to a diverse segment of the population.
In addition to its core insurance offerings, Humana is a frontrunner in stand-alone prescription drug plans, particularly for seniors enrolled in traditional fee-for-service Medicare. This is part of their broader commitment to ensuring comprehensive healthcare accessibility for all members.
Humana continuously strives to innovate and improve its services, recognizing that healthcare needs are dynamic and vary among individuals, families, and communities. The company's cultural foundation is deeply rooted in helping members achieve optimal health by delivering personalized and simplified healthcare experiences. Their array of services includes not only medical insurance but also primary-care services, at-home healthcare services, and pharmacy benefit management.
The company's recent achievements and current projects reflect its commitment to holistic health solutions. Through CenterWell, Humana provides the latest updates and resources aimed at helping people live their healthiest lives on their terms, whenever and wherever they need it.
Humana's employees are central to its mission. The company has built an organization of dynamic talent, whose experience and passion are focused on putting the customer first. This dedication is evident in their innovative approach to healthcare, which continuously adapts to meet evolving needs.
With its strong financial condition and strategic partnerships, Humana is well-positioned to continue its leadership in the healthcare industry. Whether you are an investor looking for reliable stock performance or a member seeking high-quality healthcare services, Humana remains a standout choice.
Humana Inc. (NYSE: HUM) has declared a cash dividend of $0.7875 per share, reflecting a 12.5% increase from the previous $0.70 dividend. This dividend is payable on April 29, 2022, to stockholders of record as of March 31, 2022. Humana aims to enhance health outcomes and manage costs through integrated care, benefiting millions of members, including Medicare recipients and military personnel. The company provides a range of resources, such as in-home care and behavioral health services, to simplify healthcare access and improve member well-being.
Humana Inc. (NYSE: HUM), in collaboration with The Humana Foundation and the University of Louisville, announced a $25 million investment in the Health Equity Innovation Hub. This initiative aims to enhance health equity for marginalized populations in Louisville and beyond. The funding includes $1.5 million from Humana and up to $13.5 million from The Humana Foundation, marking one of the largest donations in UofL’s history. The Hub will focus on research, talent development, and entrepreneurship, addressing social determinants of health to improve overall health outcomes.
Humana Inc. (NYSE: HUM) has received notification from the Louisiana Department of Health to award a contract for providing Medicaid coverage in Louisiana. The Medicaid division, Humana Healthy Horizons, plans to commence service later this year, contingent on completing the protest period. The initiative aims to enhance health outcomes for 1.6 million Medicaid beneficiaries in Louisiana through a holistic care approach. This selection underscores Humana's commitment to improving community health and supporting urgent needs through programs addressing social determinants of health.
Humana Inc. (NYSE: HUM) announced that CEO Bruce D. Broussard will present at the 11th Annual SVB Leerink Global Healthcare Conference on February 18, 2022, at 11:20 a.m. ET. Interested investors can access a live audio webcast on Humana’s Investor Relations page at humana.com. The company emphasizes its commitment to integrated healthcare, aiming to improve health and reduce costs for its members through various services, including in-home care and data analytics.
Humana Specialty Pharmacy announced the addition of two oncology therapies: TAGRISSO® (osimertinib) for EGFRm non-small cell lung cancer and LENVIMA® (lenvatinib) for various cancers. These drugs will be delivered directly to patients, supported by Humana's Oncology Center of Excellence, which offers expert guidance on treatment. Humana is dedicated to enhancing patient experiences and health outcomes while managing chronic and complex illnesses through personalized services.
Humana reported a 4Q21 loss per common share of $0.11 on a GAAP basis, while adjusted EPS stood at $1.24. For FY 2021, GAAP EPS was $22.67, down from $25.31 in FY 2020. The company anticipates FY 2022 GAAP EPS of at least $23.08 and adjusted EPS of at least $24.00, considering a $1.00 negative COVID-19 impact. Humana plans to create $1 billion in value through cost savings and productivity initiatives, focusing on its Medicare Advantage business and healthcare services expansion.
Humana Inc. (NYSE: HUM) has announced winners of its 2021 Go365 National Step Challenge, involving over 33,000 participants from various companies. Participants collectively logged 7.2 billion steps, leading to a donation of meals to local food banks, totaling an equivalent of one million meals. The challenge promotes health and community support, with winners from different divisions receiving donations in their names. The initiative has provided 4 million meals to Feeding America since its inception in 2018, addressing food insecurity while encouraging healthier lifestyles.
Humana Inc. is set to expand its CenterWell Senior Primary Care network by opening 26 new centers in 2022, enhancing access for underserved seniors across the Dallas-Ft. Worth, Phoenix, Louisville, Nashville, and Charlotte markets. This expansion will mark CenterWell's entry into Arizona, Kentucky, and Tennessee. With approximately 200 existing centers across nine states, the organization aims to increase this number to between 240-260 by year-end, improving personalized healthcare for 300,000 Medicare patients.
Humana Inc. (NYSE: HUM) has appointed Dr. Andrew Agwunobi, a seasoned health care executive, as President of its Home Solutions business, effective February 21. Dr. Agwunobi previously served as interim President of the University of Connecticut and CEO of UConn Health. He has extensive experience in health care operations, including leadership roles in various health systems. His expertise in home health care aligns with Humana's vision to enhance at-home care services, particularly in the wake of increased demand during the COVID pandemic.
FAQ
What is the current stock price of Humana (HUM)?
What is the market cap of Humana (HUM)?
What is Humana Inc.'s primary focus?
What types of healthcare services does Humana provide?
Who are Humana's primary members?
How does Humana innovate in healthcare delivery?
What is CenterWell?
Why is Humana a significant player in healthcare?
How does Humana support its mission through its employees?
What sets Humana apart from other health insurers?
What recent achievements has Humana made?
How does Humana's cultural foundation influence its operations?
